Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve 1. To consider and approve Unaudited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Ltd has informed BSE that its Board of Directors will meet on Monday, 09 February 2026 at the registered office in Mumbai. The main item on the agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results along with the Limited Review Report for the quarter ended 31 December 2025 (Q3 FY26). Any other business matter may be taken up with the Chairman's permission. The trading window for directors, designated persons and their relatives is closed from 01 January 2026 until 48 hours after results are declared, as per insider trading rules.
This is a routine pre-results intimation and carries no direct impact on shareholders. Investors should watch for the actual Q3 FY26 numbers when announced on or after 09 February 2026 for any signs of revenue or profit changes.